Artificial Pancreas Device System Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts
Discover trends, market shifts, and competitive outlooks for the artificial pancreas device system industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Milestones in the Artificial Pancreas Device System Market’s Growth Trajectory From 2025 To 2034?
Recent years have seen swift growth in the market size of the artificial pancreas device system. The market, which was worth $1.81 billion in 2024, is projected to rise to $2.07 billion in 2025, recording a compound annual growth rate (CAGR) of 14.1%. This notable growth during the historically significant period can be credited to a surge in investments, increasing governmental initiatives devoted to clinical research, a rising demand for automated systems specific to glycemic control, intense R&D activities advanced by industry players, and a boost in the geriatric population.
Anticipated to experience a swift expansion in the coming years, the market size of the artificial pancreas device system is predicted to reach $3.48 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.9%. This projected growth during the forecast period can be associated with a rise in diabetes prevalence, an escalation in pancreatic cancer cases, an increase in diabetes and obesity incidents, a surge in demand for minimally invasive (MI) drug delivery systems, and advancements in diabetes management technology. The forecast period is also expected to see major trends such as technological innovations, a boost in research and development activities, a rise in product approvals, the growth of partnerships and collaborations, and an increase in tele-consultancy activities for patient follow-up.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp
What External and Internal Drivers Are Contributing to the Growth of the Artificial Pancreas Device System Market?
The growth of the artificial pancreas device system market is anticipated to be fueled by the rising incidence of pancreatic cancer. This type of cancer is a harmful tumor that starts in the pancreas, a gland situated behind the stomach. Various factors including lifestyle, genetic attributes, medical history, and environment, along with genetic changes causing hereditary pancreatitis leading to chronic pancreas inflammation, contribute to pancreatic cancer. The primary function of an artificial pancreas device system (APDS) is to assist diabetes patients in managing their blood glucose levels by automatically tracking glucose levels and administering the required insulin dosage. For example, Cancer Australia, a government agency, projected that there were 4,506 new pancreatic cancer diagnoses in 2023, marking an increase from the 3,751 cases recorded over the previous five years. Thus, the escalating incidence of pancreatic cancer is propelling the expansion of the artificial pancreas device system market.
What Segment Types Define the Artificial Pancreas Device System Market Structure?
The artificial pancreas device system market covered in this report is segmented –
1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users
Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Artificial Pancreas Device System Market?
North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Artificial Pancreas Device System Market?
Major corporations involved in the artificial pancreas device system market are focusing on the advancement of automated insulin delivery systems. These systems are designed to improve diabetes management by autonomously tracking blood glucose levels and dispensing the required insulin dose. The objective of automated insulin supply systems is to mimic the functioning of a healthy pancreas, consequently alleviating the demand for ongoing monitoring of blood sugar levels and manual insulin injections for people living with diabetes. To illustrate, Beta Bionics, a US medical equipment producer, got FDA 510(k) clearance for the iLet Insulin-Only Bionic Pancreas System in May 2023. This is an automated insulin dispensing device, an artificial pancreas system that independently determines and administers insulin amounts to regulate blood glucose levels. The device is a closed-loop system that adjusts insulin delivery based on the glucose levels recorded by an attached continuous glucose monitor (CGM). It only needs to know the user’s body weight and an estimated meal size to automatically regulate insulin supply.
View the full report here:
What Is the Definition of the Artificial Pancreas Device System Market?
Artificial pancreas device system (APDS) is a medical technology designed to automate blood glucose control for individuals with diabetes. The system integrates continuous glucose monitoring (CGM) with an insulin pump, and uses a sophisticated algorithm to automatically adjust insulin delivery based on real-time glucose readings. The device aims to mimic the glucose-regulating function of a healthy pancreas, thereby reducing the need for manual blood glucose monitoring and insulin injections, and helping to maintain blood glucose levels within a target range.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
